Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

The US Food and Drug Administration (FDA) has approved updated mRNA vaccines from Moderna and Pfizer/BioNTech that protect ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Moderna’s new Laval-based facility supports onshore vaccine production, bolsters health and economic resilience, and ...

CAMBRIDGE, MA / ACCESS Newswire / September 19, 2025 / Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territories. This milestone ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...